Secondary Logo

Journal Logo

Most Popular Articles

Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: A Systematic Review

GarcĂ­a, SaĂ­nza; MartĂ­nez-Cengotitabengoa, MĂ³nica; LĂ³pez-Zurbano, Saioa; More

Journal of Clinical Psychopharmacology. 36(4):355-371, August 2016.

Efficacy and Safety of Paliperidone Palmitate Treatment in Patients With Schizophrenia: A Real-World Multicenter, Retrospective, Mirror-Image Study

Devrimci-Ozguven, Halise; Atmaca, Murad; Baran, Zeynep; More

Journal of Clinical Psychopharmacology. 39(6):604-610, November/December 2019.

A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive Dyskinesia

Marder, Stephen R.; Singer, Carlos; Lindenmayer, Jean-Pierre; More

Journal of Clinical Psychopharmacology. 39(6):620-627, November/December 2019.

Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis

Andorn, Anne C.; Haight, Barbara R.; Shinde, Sunita; More

Journal of Clinical Psychopharmacology. 40(3):231-239, May/June 2020.

N-Acetylcysteine Add-On Treatment in Refractory Obsessive-Compulsive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

Afshar, Hamid; Roohafza, Hamidreza; Mohammad-Beigi, Hamid; More

Journal of Clinical Psychopharmacology. 32(6):797-803, December 2012.

Efficacy of Sertraline in Patients With Major Depressive Disorder Naive to Selective Serotonin Reuptake Inhibitors: A 10-Week Randomized, Multicenter, Placebo-Controlled, Double-Blind, Academic Clinical Trial

Valle-Cabrera, Roselin; Mendoza-RodrĂ­guez, Yudexi; Robaina-GarcĂ­a, Maytee; More

Journal of Clinical Psychopharmacology. 38(5):454-459, October 2018.

Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine: A Pragmatic Randomized Controlled Trial (CYSCE Trial)

van der Schans, Jurjen; Hak, Eelko; Postma, Maarten; More

Journal of Clinical Psychopharmacology. 39(6):583-590, November/December 2019.

Assessment of the Abuse Potential of Cebranopadol in Nondependent Recreational Opioid Users: A Phase 1 Randomized Controlled Study

Göhler, Karin; Sokolowska, Marta; Schoedel, Kerri A.; More

Journal of Clinical Psychopharmacology. 39(1):46-56, January/February 2019.

Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study

Sanches, Rafael Faria; de Lima OsĂ³rio, FlĂ¡via; dos Santos, Rafael G.; More

Journal of Clinical Psychopharmacology. 36(1):77-81, February 2016.

Comparison of Paliperidone Palmitate and Risperidone Long-Acting Injection in Schizophrenic Patients: Results From a Multicenter Retrospective Cohort Study in France

Limosin, Frédéric; Belhadi, Drifa; Comet, Denis; More

Journal of Clinical Psychopharmacology. 38(1):19-26, February 2018.

Speed of Improvement in Symptoms of Depression With Desvenlafaxine 50 mg and 100 mg Compared With Placebo in Patients With Major Depressive Disorder

Katzman, Martin A.; Nierenberg, Andrew A.; Wajsbrot, Dalia B.; More

Journal of Clinical Psychopharmacology. 37(5):555-561, October 2017.

Zonisamide, Topiramate, and Levetiracetam: Efficacy and Neuropsychological Effects in Alcohol Use Disorders

Knapp, Clifford M.; Ciraulo, Domenic A.; Sarid-Segal, Ofra; More

Journal of Clinical Psychopharmacology. 35(1):34-42, February 2015.

Long-Term Effect of Haloperidol, Olanzapine, and Risperidone on Plasma Prolactin Levels in Patients With First-Episode Psychosis

Pérez-Iglesias, Rocio; Mata, Ignacio; Martínez-García, Obdulia; More

Journal of Clinical Psychopharmacology. 32(6):804-808, December 2012.

Paliperidone Palmitate Once-Monthly Injectable Treatment for Acute Exacerbations of Schizoaffective Disorder

Fu, Dong-Jing; Turkoz, Ibrahim; Simonson, R. Bruce; More

Journal of Clinical Psychopharmacology. 36(4):372-376, August 2016.

RE-KINECT: A Prospective Study of the Presence and Healthcare Burden of Tardive Dyskinesia in Clinical Practice Settings

Caroff, Stanley N.; Yeomans, Karen; Lenderking, William R.; More

Journal of Clinical Psychopharmacology. 40(3):259-268, May/June 2020.

Antidepressant-Associated Mania in Bipolar Disorder: A Review and Meta-analysis of Potential Clinical and Genetic Risk Factors

Melhuish Beaupre, Lindsay M.; Tiwari, Arun K.; Gonçalves, Vanessa F.; More

Journal of Clinical Psychopharmacology. 40(2):180-185, March/April 2020.

Six-Month Randomized, Placebo-Controlled, Double-Blind, Pilot Clinical Trial of Curcumin in Patients With Alzheimer Disease

Baum, Larry; Lam, Christopher Wai Kei; Cheung, Stanley Kwok-Kuen; More

Journal of Clinical Psychopharmacology. 28(1):110-113, February 2008.

A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults

Richards, Cynthia; Iosifescu, Dan V.; Mago, Rajnish; More

Journal of Clinical Psychopharmacology. 38(4):336-343, August 2018.

Assessment of Pharmacokinetic and Pharmacodynamic Interactions Between Albumin-Fused Mutated Butyrylcholinesterase and Intravenously Administered Cocaine in Recreational Cocaine Users

Shram, Megan J.; Cohen-Barak, Orit; Chakraborty, Bijan; More

Journal of Clinical Psychopharmacology. 35(4):396-405, August 2015.

Comparison of the Efficacy and Safety of Aripiprazole Versus Bupropion Augmentation in Patients With Major Depressive Disorder Unresponsive to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-Label Study

Cheon, Eun-Jin; Lee, Kwang-Hun; Park, Young-Woo; More

Journal of Clinical Psychopharmacology. 37(2):193-199, April 2017.

The Effects of a Gluten-Free Diet on Immune Markers and Kynurenic Acid Pathway Metabolites in Patients With Schizophrenia Positive for Antigliadin Antibodies Immunoglobulin G

Friendshuh, C. Renay; Pocivavsek, Ana; Demyonovich, Haley; More

Journal of Clinical Psychopharmacology. 40(3):317-319, May/June 2020.

An Alzheimer Disease Challenge Model: 24-Hour Sleep Deprivation in Healthy Volunteers, Impact on Working Memory, and Reversal Effect of Pharmacological Intervention: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Chan Kwong, Anna; Cassé-Perrot, Catherine; Costes-Salon, Marie-Claude; More

Journal of Clinical Psychopharmacology. 40(3):222-230, May/June 2020.

The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder: A Second Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

Marcus, Ronald N.; McQuade, Robert D.; Carson, William H.; More

Journal of Clinical Psychopharmacology. 28(2):156-165, April 2008.

Assessment of the Abuse Potential of the Orexin Receptor Antagonist, Suvorexant, Compared With Zolpidem in a Randomized Crossover Study

Schoedel, Kerri A.; Sun, Hong; Sellers, Edward M.; More

Journal of Clinical Psychopharmacology. 36(4):314-323, August 2016.

A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients

Zabala, Arantzazu; Bustillo, Mariana; Querejeta, Imanol; More

Journal of Clinical Psychopharmacology. 37(5):569-577, October 2017.

Show: